Development History
Development History
2002
Zhifei Biologicals Was Founded, Officially Entered the Biopharmaceutical Industry.
2003
Established Its First R&D And Production Base, Beijing Zhifei Lvzhu
2008
Acquired and Established Anhui Zhifei Longcom, the Second Major R&D and Manufacturing Base.
2010
Listed on The Growth Enterprise Market (GEM) of The Shenzhen Stock Exchange.
2011
Strategic Cooperation With Merck & Co., Inc. (MSD) Began.
2014
Investment in Chongqing Zhirui: Strategic Positioning in the Macro-Biopharmaceutical Field
2017
Exclusive Distributor for Quadrivalent HPV Vaccine (Gardasil®) in China
2018
Exclusive Distributor for 9-Valent HPV Vaccine (Gardasil 9) in China
2023
Strategic Cooperation With Glaxosmithkline (GSK) Began.
2025
Boosting Stake in Chongqing Chen'an Biotech: Expanding Into Metabolic Disease Treatments
2002
2003
2008
2010
2011
2014
2017
2018
2023
2025
Social Honor
Social Honor
All
Fortune Global Future 50 (2021)
Top 10 Global Vaccine Companies (2021)
Forbes Global 2000 (2022)
Fortune China 500 (2024)
Fortune Global Future 50 (2021)
Top 10 Global Vaccine Companies (2021)
Forbes Global 2000 (2022)
Fortune China 500 (2024)